Cargando…
Sex Differences in the Metabolome of Alzheimer's Disease Progression
Alzheimer's disease (AD) is the leading cause of dementia; however, men and women face differential AD prevalence, presentation, and progression risks. Characterizing metabolomic profiles during AD progression is fundamental to understand the metabolic disruptions and the biological pathways in...
Autores principales: | González Zarzar, Tomás, Lee, Brian, Coughlin, Rory, Kim, Dokyoon, Shen, Li, Hall, Molly A. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9014653/ https://www.ncbi.nlm.nih.gov/pubmed/35445209 http://dx.doi.org/10.3389/fradi.2022.782864 |
Ejemplares similares
-
Manual Planimetry of the Medial Temporal Lobe Versus Automated Volumetry of the Hippocampus in the Diagnosis of Alzheimer's Disease
por: Menéndez González, Manuel, et al.
Publicado: (2016) -
Adversarial counterfactual augmentation: application in Alzheimer’s disease classification
por: Xia, Tian, et al.
Publicado: (2022) -
Integrating Transcriptomics, Genomics, and Imaging in Alzheimer's Disease: A Federated Model
por: Wu, Jianfeng, et al.
Publicado: (2022) -
A Quandary of Cuprum - Wilson’s Disease Disguising as Progressive Myoclonic Epilepsy
por: Sachan, Monika, et al.
Publicado: (2017) -
Routine In-Hospital Radiographs Following Anterior Cervical Discectomy and Fusion Surgery: Neither Necessary nor Cost-Effective?
por: McCabe, Rory M, et al.
Publicado: (2021)